EMD-16490

Single-particle
4.1 Å
EMD-16490
3D View Gallery
Deposition: 20/01/2023
Map released: 22/02/2023
Last modified: 20/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-16490

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-8c8p summary report (pdf.gz) Map-8c8p FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Structure of the SARS-CoV-2 spike glycoprotein in complex with the 10D12 heavy-chain-only antibody (local refinement)

EMD-16490

Single-particle
4.1 Å
EMD-16490
3D View Gallery
Deposition: 20/01/2023
Map released: 22/02/2023
Last modified: 20/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2, Mus musculus
Sample: SARS-CoV-2 spike glycoprotein in complex with the 10D12 heavy-chain-only antibody
Fitted models: 8c8p

Deposition Authors: Serna Martin I , Hurdiss DL
Avidity engineering of human heavy-chain-only antibodies mitigates neutralization resistance of SARS-CoV-2 variants.
Du W , Janssens R, Mykytyn AZ, Li W , Drabek D, van Haperen R, Chatziandreou M, Rissmann M, van der Lee J , van Dortmondt M, Martin IS, van Kuppeveld FJM, Hurdiss DL , Haagmans BL , Grosveld F, Bosch BJ
(2023) Front Immunol , 14 , 1111385 - 1111385
PUBMED: 36895554
DOI: doi:10.3389/fimmu.2023.1111385
ISSN: 1664-3224